GE HealthCare Technologies Inc. $GEHC Shares Bought by Locust Wood Capital Advisers LLC

Locust Wood Capital Advisers LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,084,337 shares of the company’s stock after acquiring an additional 137,992 shares during the period. GE HealthCare Technologies makes up 3.9% of Locust Wood Capital Advisers LLC’s portfolio, making the stock its 8th biggest position. Locust Wood Capital Advisers LLC owned approximately 0.46% of GE HealthCare Technologies worth $156,534,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Allianz SE raised its holdings in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. increased its position in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after acquiring an additional 196 shares during the period. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Gladwyn Financial Advisors Inc. bought a new position in shares of GE HealthCare Technologies in the second quarter worth $34,000. Finally, Piscataqua Savings Bank increased its holdings in shares of GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after purchasing an additional 300 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 2.9%

GEHC opened at $81.10 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The business has a 50 day moving average price of $81.69 and a 200 day moving average price of $77.13. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The firm has a market cap of $36.94 billion, a P/E ratio of 16.76, a price-to-earnings-growth ratio of 2.38 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Wall Street Analyst Weigh In

GEHC has been the topic of several research analyst reports. Citigroup raised their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, January 7th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their target price for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Finally, Bank of America increased their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $89.83.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.